Administration of Lactulose in NPO Patients
For patients who are NPO (nil per os), lactulose should be administered as a retention enema consisting of 300 mL lactulose mixed with 700 mL water, given 3-4 times daily until clinical improvement is noted. 1, 2, 3
Rectal Administration Protocol
- Prepare the enema solution by mixing 300 mL of lactulose with 700 mL of water or physiological saline 1, 3
- Administer via a rectal balloon catheter or enema equipment 3
- The solution should be retained in the intestine for at least 30 minutes to ensure maximum effectiveness 1, 3
- May repeat every 4-6 hours as needed, particularly in severe hepatic encephalopathy (HE) cases 3
- Continue until clinical improvement is observed or oral administration becomes possible 1, 3
Clinical Considerations
This approach is specifically indicated for patients with:
The goal is to achieve the same therapeutic effect as oral administration:
Monitoring and Adjustments
- Monitor for clinical improvement in mental status 1
- Assess electrolytes regularly to prevent dehydration and hypernatremia 1
- Once the patient improves and can take oral medications, transition to oral lactulose 3
- For oral dosing after improvement, start with 20-30g (30-45 mL) 3-4 times daily, titrated to achieve 2-3 soft stools per day 4, 2
Alternative Approaches
- In patients with ileus, oral lactulose should be held 1
- If a nasogastric tube is in place and there are no contraindications (such as recent variceal band ligation), lactulose can be administered through the nasogastric tube 1, 5
- Polyethylene glycol may be considered as an alternative in patients at risk for ileus or abdominal distention 1
Common Pitfalls and Cautions
- Avoid cleansing enemas containing soap suds or other alkaline agents before lactulose administration 3
- If the enema is evacuated too promptly, it may be repeated immediately 3
- Be vigilant for complications such as dehydration, hypernatremia, and perianal skin irritation 2
- Overuse of lactulose can paradoxically precipitate hepatic encephalopathy 4, 2
Following this protocol ensures effective delivery of lactulose therapy in NPO patients while minimizing potential complications until oral administration becomes possible.